1. Home
  2. CSBR vs RDNW Comparison

CSBR vs RDNW Comparison

Compare CSBR & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • RDNW
  • Stock Information
  • Founded
  • CSBR 1985
  • RDNW 2013
  • Country
  • CSBR United States
  • RDNW United States
  • Employees
  • CSBR N/A
  • RDNW N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • RDNW EDP Services
  • Sector
  • CSBR Health Care
  • RDNW Technology
  • Exchange
  • CSBR Nasdaq
  • RDNW Nasdaq
  • Market Cap
  • CSBR 123.2M
  • RDNW 147.3M
  • IPO Year
  • CSBR 1986
  • RDNW N/A
  • Fundamental
  • Price
  • CSBR $6.42
  • RDNW $4.34
  • Analyst Decision
  • CSBR Strong Buy
  • RDNW
  • Analyst Count
  • CSBR 1
  • RDNW 0
  • Target Price
  • CSBR $12.00
  • RDNW N/A
  • AVG Volume (30 Days)
  • CSBR 40.7K
  • RDNW 44.5K
  • Earning Date
  • CSBR 09-15-2025
  • RDNW 11-11-2025
  • Dividend Yield
  • CSBR N/A
  • RDNW N/A
  • EPS Growth
  • CSBR N/A
  • RDNW N/A
  • EPS
  • CSBR 0.21
  • RDNW N/A
  • Revenue
  • CSBR $56,878,000.00
  • RDNW $1,109,200,000.00
  • Revenue This Year
  • CSBR $9.30
  • RDNW N/A
  • Revenue Next Year
  • CSBR $31.17
  • RDNW $7.73
  • P/E Ratio
  • CSBR $29.53
  • RDNW N/A
  • Revenue Growth
  • CSBR 10.11
  • RDNW N/A
  • 52 Week Low
  • CSBR $3.75
  • RDNW $1.46
  • 52 Week High
  • CSBR $11.99
  • RDNW $7.06
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 46.30
  • RDNW N/A
  • Support Level
  • CSBR $6.27
  • RDNW N/A
  • Resistance Level
  • CSBR $6.90
  • RDNW N/A
  • Average True Range (ATR)
  • CSBR 0.29
  • RDNW 0.00
  • MACD
  • CSBR -0.02
  • RDNW 0.00
  • Stochastic Oscillator
  • CSBR 23.37
  • RDNW 0.00

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About RDNW RideNow Group Inc. Class B Common Stock

RideNow Group Inc is a USA-based online retailer that allows consumers and dealers both to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience.

Share on Social Networks: